Jyseleca 100 mg film-coated tablets, Jyseleca 200 mg film-coated tablets, Composition apart from the active substance otherwise to identical to IMP
GS-US-418-3899
Phase 3 small_molecule active
Quick answer
Jyseleca 100 mg film-coated tablets, Jyseleca 200 mg film-coated tablets, Composition apart from the active substance otherwise to identical to IMP for Ulcerative Colitis (UC) is a Phase 3 program (small_molecule) at Alfasigma S.p.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Alfasigma S.p.A.
- Indication
- Ulcerative Colitis (UC)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active